Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Atsena Publishes 12-Month Data on ATSN-101 for LCA1
Atsena Therapeutics announced that 12-month safety and efficacy data from its Phase I/II trial of ATSN-101, a gene therapy for Leber congenital amaurosis caused by GUCY2D mutations (LCA1), were published in The Lancet. ATSN-101 showed durable improvements in vision at…
$6.4M Grant for New Dry AMD & Stargardt Treatments
Dr. Christopher Cioffi, the Thomas and Constance D’Ambra Professor in Organic Chemistry at Rensselaer Polytechnic Institute, is collaborating with Dr. Konstantin Petrukhin, Professor of Ophthalmic Science at Columbia University, to develop promising compounds aimed at treating dry age-related macular degeneration…
Promising Drug for Preventing Diabetic Eye and Kidney Disease
New research led by the University of Bristol has identified a promising type of inhibitor drug that could potentially prevent microvascular diabetic complications, including diabetic eye and kidney disease. The study, published in Cardiovascular Diabetology, focuses on protecting the glycocalyx,…
Aviceda’ Kicks off Phase II/III SIGLEC Trial for AMD
Aviceda Therapeutics has initiated the second part of its Phase II/III SIGLEC trial for AVD-104, an ophthalmic candidate aimed at treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The company has dosed the first subject in this phase,…
How Smoking Affects Your Eye Health
Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, and stroke. However, the harmful effects of smoking extend beyond these well-known conditions, significantly impacting eye health as well.…
Foundation Fighting Blindness Launches Gyrate Atrophy Study
The Foundation Fighting Blindness has launched a natural history study targeting gyrate atrophy, a rare and sight-threatening inherited retinal disease. Spearheading this initiative are esteemed researchers Dr. Mandeep S. Singh, MD, PhD, and Dr. David Valle, MD, from the Wilmer…
Microbial Keratitis (MK) | OBN
Contact lens wearing has been increased globally during recent decades, which is one of the main risk factors for developing microbial keratitis. Microbial keratitis is a severe and dangerous condition that causes cornea inflammation. Potential Complications of Microbial Keratitis It…
Calcium Channel Blockers Increase Risk of Glaucoma
A comprehensive meta-analysis revealed that the use of calcium channel blockers (CCBs), particularly cardioselective agents, was associated with a modest but statistically significant risk of glaucoma. The analysis indicated that patients with a prior history of CCB treatment had a…
Is Areds 2 Supplement Good for AMD?
AMD stands for age-related macular degeneration and it is an eye disease where your vision is blurred. Using Areds 2 supplement depends on the stage you have the blurry vision either early intermediate or late. Also depending on AMD in…
Peters Anomaly: Causes, Symptoms and Management
What Is Peters Anomaly? Peters anomaly is a rare congenital ocular condition primarily affecting the anterior segment of the eye. At its core, it’s characterized by the abnormal development of the cornea’s central layers and potential adhesions between the cornea…